FutureCure Health secured $11.5M led by Carnelian Asset Management to expand vertigo treatment access through NeuroEquilibrium. Founded by Rajneesh and Anita Bhandari, NeuroEquilibrium uses advanced diagnostics to identify vertigo’s root cause, providing targeted treatment. This funding will extend NeuroEquilibrium’s reach beyond urban centers, addressing neuro-otology care globally and integrating cloud platforms with deep-tech innovations. Operating 300+ clinics in India and 16 countries, it has treated over 150,000 patients, aiming to democratize super-speciality healthcare and tackle conditions like migraine and diabetes.
Trending
- Fraganote Secures $3 Million Series A to Propel D2C Growth and Portfolio Expansion
- Fraganote Secures $3 Million Series A to Propel D2C Growth and Portfolio Expansion
- Amazon Prime Music in India to Introduce Ads, Remove Offline Downloads From July 2026
- Amazon Prime Music in India to Introduce Ads, Remove Offline Downloads From July 2026
- Acko Taps Top Banks for H1 2027 IPO Target
- Fairdeal.Market Secures US$15M to Scale B2B Quick Commerce Across India
- India’s Startup IPO Surge: 48+ Listings Set to Unlock INR 50,000 Cr in 2026
- Indian Startup IPO Surge Expected by 2026 Amid Market Reset


